10-K: Kun Peng International Ltd. Reports Fiscal Year 2024 Results Amidst Restructuring and Regulatory Scrutiny
Annual Results
Kun Peng International Ltd. reports its fiscal year 2024 results, highlighting a net loss and ongoing challenges related to its VIE structure and regulatory environment in China.
Summary
- Kun Peng International Ltd. reported a net loss of $1,991,747 for the fiscal year ended September 30, 2024, compared to a net loss of $2,149,213 in the previous year.
- The company's revenue decreased to $2,078,741 in 2024 from $3,917,335 in 2023, primarily due to a decline in wholesale revenue.
- Operating expenses totaled $3,473,901 in 2024, a decrease from $5,733,003 in 2023, due to reductions in both selling and general and administrative expenses.
- The company's cash and cash equivalents decreased to $82,184 as of September 30, 2024, from $457,580 in the previous year.
- The report highlights the company's reliance on a variable interest entity (VIE) structure in China, which carries significant regulatory and operational risks.
- The company is focusing on its online platforms, King Eagle Mall and Kun Zhi Jian, to mitigate the adverse impacts of COVID-19 and to promote its own brand of preventive health care products.
- The company is also exploring strategic relationships with health service providers to offer integrated health services to its members.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While there are some positive developments, such as the launch of new platforms and cost-cutting measures, the significant decrease in revenue, ongoing losses, and regulatory risks associated with the VIE structure and operations in China create a negative outlook. The company's ability to continue as a going concern is also a major concern.
Positives
- The company's net loss decreased compared to the previous year.
- Operating expenses were reduced, indicating cost-cutting measures.
- The company is actively developing new online platforms and expanding its customer services.
- The company is exploring strategic relationships to provide comprehensive health services.
Negatives
- The company experienced a significant decrease in revenue compared to the previous year.
- The company's cash and cash equivalents decreased substantially.
- The company continues to operate at a loss.
- The company's reliance on a VIE structure in China poses significant regulatory and operational risks.
Risks
- The company's ability to continue as a going concern is dependent on raising additional funds and implementing its business plan.
- The VIE structure used by the company is subject to regulatory risks and may be disallowed by the Chinese government.
- The company's operations are subject to complex and evolving laws and regulations regarding privacy and data protection in China.
- The company relies on dividends and other distributions from its subsidiaries, which may be restricted by PRC law.
- The company may be subject to scrutiny, criticism, and negative publicity involving U.S.-listed China-based companies.
- The company's securities could be delisted and prohibited from trading on a U.S. exchange if its auditors' documentation is located in China or Hong Kong and not available for PCAOB inspection.
- The company faces political risks associated with conducting business in China and Hong Kong.
- The company's business is subject to complex and evolving laws and regulations regarding privacy and data protection.
- The company may face obstacles from the communist system in the PRC.
Future Outlook
The company intends to focus on its online platforms, streamline overhead costs, and seek additional financing to support its operations and growth. The company also plans to expand its customer services and preventive health care products through the Kun Zhi Jian Mini Program.
Management Comments
- Management believes preventive care is the most effective investment in health.
- Management believes that we are in a new era of e-commerce and that additional characteristics of sharing economy, offline support and social interaction are evolving.
- Management believes the rise of social e-commerce will positively impact the development of our health care business.
Industry Context
The report notes that China's health food market is projected to expand significantly, reaching an estimated RMB244 billion (US$34.3 billion) by 2025. The company is positioning itself to capitalize on this growth through its online platforms and health-related products and services.
Comparison to Industry Standards
- The company's reliance on a VIE structure is common among U.S.-listed Chinese companies, but it carries significant regulatory risks.
- The company's focus on e-commerce aligns with the trend of increasing online sales in the Chinese health food market, where e-commerce accounts for 40% of sales.
- The company's S2B2C model is an innovative approach to e-commerce, aiming to provide more thorough services to customers.
- The company's strategy of integrating health care services with product sales is similar to other companies in the health and wellness industry.
- The company's financial results are below industry standards for profitability and revenue growth, indicating a need for improvement in its business operations.
Related Party Transactions
- On April 3, 2024, KP (Tianjin) entered into a Share Transfer Agreement with Zhandong Fan and Yuanyuan Zhang for the acquisition of all the subscribed shares of Kun Pin Hui (Shandong) Trading Co. Ltd.
- The company has various related party transactions, including loans and payments for services with its shareholders and related entities.
Stakeholder Impact
- Shareholders face significant risks due to the company's VIE structure and regulatory environment in China.
- Employees may be affected by the company's cost-cutting measures and potential restructuring.
- Customers may experience changes in the company's product offerings and services.
- Suppliers may be impacted by the company's financial challenges and potential changes in sourcing strategies.
- Creditors face risks due to the company's negative working capital and potential inability to meet its obligations.
Next Steps
- The company will focus on promoting and selling its own brand of preventive health care products through its online platform, Kun Zhi Jian.
- The company will streamline its overhead costs.
- The company will seek additional financing or capital funding from its stockholders or directors.
- The company will continue to monitor and assess the evolving situation closely and evaluate its potential exposure to COVID-19.
Key Dates
| Date | Description |
|---|---|
| 2017-08-11 | Kun Peng (China) Industrial Development Company Limited incorporated in Hong Kong. |
| 2019-03-20 | King Eagle (China) Co., Ltd. incorporated in the PRC. |
| 2020-09-02 | King Eagle (Tianjin) Technology Co., Ltd. incorporated in the PRC. |
| 2021-04-20 | Kun Peng International Holding Limited incorporated in the British Virgin Islands. |
| 2021-05-15 | King Eagle (China) entered into VIE Agreements with King Eagle (Tianjin). |
| 2021-06-21 | Kun Peng (Hong Kong) Industrial Development Limited incorporated in Hong Kong. |
| 2021-08-10 | Kun Peng Tian Yu Health Technology (Tianjin) Co., Ltd. established in the PRC. |
| 2022-11-08 | Company name changed to Kun Peng International Ltd. |
| 2022-11-14 | Company's securities commenced trading on the OTCQB. |
| 2022-12-01 | King Eagle (Beijing) Technology Co., Ltd. established in the PRC. |
| 2023-03-03 | King Eagle (China) is no longer a WFOE. |
| 2023-09-19 | King Eagle (Huaian) Health Management Co., Ltd. established in the PRC. |
| 2023-10-26 | Kun Zhi Jian (Huaian) Technology Co., Ltd. established in the PRC. |
| 2024-01-30 | Kun Zhi Jian (Shandong) Health Management Co., Ltd. established in the PRC. |
| 2024-02-01 | Chengdu Wenjiang Pengrun Internet Healthcare Co., Ltd. established in the PRC. |
| 2024-04-07 | Kun Pin Hui (Shandong) Trading Co., Ltd. acquired by King Eagle (Tianjin). |
| 2024-07-18 | King Eagle (Hangzhou) Health Technology Co., Ltd. established in the PRC. |
| 2024-07-19 | King Eagle (Tianjin) acquired the remaining 5% registered capital of King Eagle (Huaian). |
| 2024-09-30 | End of fiscal year 2024. |
| 2025-01-13 | Date of share count. |
Keywords
VIE structure, China, online platform, health care products, regulatory risks, financial results, e-commerce, preventive health, data protection, operating expenses
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.